Diabetes Studies

Correction to: Slow Digestible Starch in Native Pea Starch (Pisum sativum L.) Lowers Glycemic Response with No Adverse Effects on Gastrointestinal Symptoms in Healthy Adults'' by Perreau et al. J Med Food 2023;26(10):760-767; doi: 10.1089/jmf.2023.0085.

(2023).
J Med Food.
PubMed:
38060726

Fractionation of Xanthium strumarium L. foliage phenolics, in-vitro antioxidant activities, and in-vivo anti-diabetic potential.

Researchers found that the ethyl acetate fraction of L. (XSL) foliage had the highest phenolic content and effectively reduced blood glucose levels in diabetic mice, suggesting its potential as an anti-diabetic agent.

Shaheen A et al (2023).
Front Chem.
PubMed:
38053673

Evidential support for garlic supplements against diabetic kidney disease: a preclinical meta-analysis and systematic review.

Garlic supplementation improved kidney function and metabolic disorders in animal models of diabetic kidney disease. Research suggests that doses of 500mg/kg for 8-10 weeks were most effective, but further studies are required. (33 words)

Jiang Y et al (2023).
Food Funct.
PubMed:
38051214

Okra [Abelmoschus esculentus (L.) Moench] improved blood glucose and restored histopathological alterations in splenic tissues in a rat model with streptozotocin-induced type 1 diabetes through CD8(+) T cells and NF-kβ expression.

This study investigated the effects of okra extract on diabetic rat models. Okra improved blood glucose levels, reversed histopathological alterations in spleen tissue, and regulated CD8 T cells and NF-kβ expression.

Alblihd MA et al (2023).
Front Vet Sci.
PubMed:
38046568

Reversal of mitochondrial permeability transition pore and pancreas degeneration by chloroform fraction of Ocimum gratissimum (L.) leaf extract in type 2 diabetic rat model.

This study investigated the effects of the chloroform fraction of (L.) leaf (CFOG) in reversing tissue wastage in diabetes. CFOG reduced insulin resistance, improved pancreatic cell regeneration, and inhibited mitochondrial dysfunction. The main active compound in CFOG was lupanol. This suggests the potential use of CFOG as an alternative therapy for diabetes.

Salemcity AJ et al (2023).
Front Pharmacol.
PubMed:
38035005

In vitro anti-inflammatory, antidiabetic, antibacterial, and in silico studies of Ferruginan A isolated from Olea ferruginea Royle (Oleaceae).

Scientists studied the anti-inflammatory and antidiabetic effects of a compound from the Royle plant, which has been traditionally used as a painkiller and antidiabetic. Understanding its potential benefits can inform medical decisions.

Rauf A et al (2023).
Saudi Pharm J.
PubMed:
38033748

Therapeutic Benefit of Vernonia amygdalina in the Treatment of Diabetes and Its Associated Complications in Preclinical Studies.

This summary examines the potential of Vernonia amygdalina (VA) in treating diabetes mellitus (DM) and complications. VA shows strong antidiabetic properties due to its phytochemicals, providing future research prospects. As a scientist, this research offers insights into a herbal treatment for DM.

Asante DB and Wiafe GA (2023).
J Diabetes Res.
PubMed:
38033739